Search details
1.
A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer.
Clin Breast Cancer
; 16(2): 87-94, 2016 Apr.
Article
in English
| MEDLINE | ID: mdl-26454612
2.
Dose dense cyclophosphamide, methotrexate, fluorouracil is feasible at 14-day intervals: a pilot study of every-14-day dosing as adjuvant therapy for breast cancer.
Clin Breast Cancer
; 10(6): 440-4, 2010 Dec 01.
Article
in English
| MEDLINE | ID: mdl-21147686
Results
1 -
2
de 2
1
Next >
>>